JP2018104305A - External preparation and method for producing external preparation - Google Patents
External preparation and method for producing external preparation Download PDFInfo
- Publication number
- JP2018104305A JP2018104305A JP2016250048A JP2016250048A JP2018104305A JP 2018104305 A JP2018104305 A JP 2018104305A JP 2016250048 A JP2016250048 A JP 2016250048A JP 2016250048 A JP2016250048 A JP 2016250048A JP 2018104305 A JP2018104305 A JP 2018104305A
- Authority
- JP
- Japan
- Prior art keywords
- external preparation
- oil
- water
- mass
- liquid crystal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 132
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 65
- 239000004973 liquid crystal related substance Substances 0.000 claims abstract description 62
- 230000002535 lyotropic effect Effects 0.000 claims abstract description 56
- 239000002245 particle Substances 0.000 claims abstract description 45
- 229920000642 polymer Polymers 0.000 claims abstract description 28
- 238000006068 polycondensation reaction Methods 0.000 claims abstract description 27
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 17
- 239000000126 substance Substances 0.000 claims abstract description 13
- 210000002472 endoplasmic reticulum Anatomy 0.000 claims abstract description 10
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 8
- 230000001804 emulsifying effect Effects 0.000 claims abstract description 4
- 239000012071 phase Substances 0.000 claims description 42
- 239000000839 emulsion Substances 0.000 claims description 29
- 239000008346 aqueous phase Substances 0.000 claims description 9
- OGQYPPBGSLZBEG-UHFFFAOYSA-N dimethyl(dioctadecyl)azanium Chemical compound CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC OGQYPPBGSLZBEG-UHFFFAOYSA-N 0.000 claims description 7
- 230000005068 transpiration Effects 0.000 abstract description 47
- 230000001629 suppression Effects 0.000 abstract description 34
- 239000003795 chemical substances by application Substances 0.000 abstract description 27
- 238000002156 mixing Methods 0.000 abstract description 12
- 239000007788 liquid Substances 0.000 abstract description 10
- 230000000887 hydrating effect Effects 0.000 abstract 6
- 239000003921 oil Substances 0.000 description 117
- 235000019198 oils Nutrition 0.000 description 117
- 230000000052 comparative effect Effects 0.000 description 44
- 239000000499 gel Substances 0.000 description 32
- 238000011156 evaluation Methods 0.000 description 27
- 239000000203 mixture Substances 0.000 description 23
- 239000004375 Dextrin Substances 0.000 description 19
- 229920001353 Dextrin Polymers 0.000 description 19
- 238000010227 cup method (microbiological evaluation) Methods 0.000 description 19
- 235000019425 dextrin Nutrition 0.000 description 19
- 230000000694 effects Effects 0.000 description 17
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 16
- 238000009472 formulation Methods 0.000 description 15
- 210000003491 skin Anatomy 0.000 description 15
- 239000011521 glass Substances 0.000 description 14
- 239000004745 nonwoven fabric Substances 0.000 description 13
- 235000014113 dietary fatty acids Nutrition 0.000 description 11
- 239000000194 fatty acid Substances 0.000 description 11
- 229930195729 fatty acid Natural products 0.000 description 11
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 11
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 10
- 239000006185 dispersion Substances 0.000 description 10
- 229920002674 hyaluronan Polymers 0.000 description 10
- 229960003160 hyaluronic acid Drugs 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 230000008859 change Effects 0.000 description 9
- -1 isostearyl Chemical group 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- 239000002480 mineral oil Substances 0.000 description 9
- 229940058015 1,3-butylene glycol Drugs 0.000 description 8
- 235000019437 butane-1,3-diol Nutrition 0.000 description 8
- 239000002537 cosmetic Substances 0.000 description 8
- 230000003020 moisturizing effect Effects 0.000 description 8
- 230000001953 sensory effect Effects 0.000 description 8
- 229920002678 cellulose Polymers 0.000 description 7
- 239000001913 cellulose Substances 0.000 description 7
- 235000010980 cellulose Nutrition 0.000 description 7
- 238000004945 emulsification Methods 0.000 description 7
- 235000010446 mineral oil Nutrition 0.000 description 7
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 7
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 6
- 239000004166 Lanolin Substances 0.000 description 6
- 235000019388 lanolin Nutrition 0.000 description 6
- 229940039717 lanolin Drugs 0.000 description 6
- 235000010445 lecithin Nutrition 0.000 description 6
- 239000000787 lecithin Substances 0.000 description 6
- 229940067606 lecithin Drugs 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 6
- 230000008020 evaporation Effects 0.000 description 5
- 238000001704 evaporation Methods 0.000 description 5
- 239000004200 microcrystalline wax Substances 0.000 description 5
- 235000019808 microcrystalline wax Nutrition 0.000 description 5
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 5
- 239000004094 surface-active agent Substances 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 235000019484 Rapeseed oil Nutrition 0.000 description 4
- 125000004432 carbon atom Chemical group C* 0.000 description 4
- 238000004090 dissolution Methods 0.000 description 4
- 150000004665 fatty acids Chemical class 0.000 description 4
- 239000003349 gelling agent Substances 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 150000003904 phospholipids Chemical class 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 238000007711 solidification Methods 0.000 description 4
- 230000008023 solidification Effects 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 229960001231 choline Drugs 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 238000013329 compounding Methods 0.000 description 3
- 238000012790 confirmation Methods 0.000 description 3
- 230000002349 favourable effect Effects 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 229920000591 gum Polymers 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 3
- 229920005615 natural polymer Polymers 0.000 description 3
- 239000008385 outer phase Substances 0.000 description 3
- 230000002688 persistence Effects 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229920001059 synthetic polymer Polymers 0.000 description 3
- 239000001993 wax Substances 0.000 description 3
- 230000037303 wrinkles Effects 0.000 description 3
- ASWBNKHCZGQVJV-UHFFFAOYSA-N (3-hexadecanoyloxy-2-hydroxypropyl) 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(O)COP([O-])(=O)OCC[N+](C)(C)C ASWBNKHCZGQVJV-UHFFFAOYSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 2
- 240000000912 Macadamia tetraphylla Species 0.000 description 2
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 238000005411 Van der Waals force Methods 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 239000010775 animal oil Substances 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 150000001841 cholesterols Chemical class 0.000 description 2
- 239000004927 clay Substances 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- SHZIWNPUGXLXDT-UHFFFAOYSA-N ethyl hexanoate Chemical compound CCCCCC(=O)OCC SHZIWNPUGXLXDT-UHFFFAOYSA-N 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 238000001000 micrograph Methods 0.000 description 2
- 239000010466 nut oil Substances 0.000 description 2
- 229940073665 octyldodecyl myristate Drugs 0.000 description 2
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- RPACBEVZENYWOL-XFULWGLBSA-M sodium;(2r)-2-[6-(4-chlorophenoxy)hexyl]oxirane-2-carboxylate Chemical compound [Na+].C=1C=C(Cl)C=CC=1OCCCCCC[C@]1(C(=O)[O-])CO1 RPACBEVZENYWOL-XFULWGLBSA-M 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 210000000434 stratum corneum Anatomy 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- JQWAHKMIYCERGA-UHFFFAOYSA-N (2-nonanoyloxy-3-octadeca-9,12-dienoyloxypropoxy)-[2-(trimethylazaniumyl)ethyl]phosphinate Chemical compound CCCCCCCCC(=O)OC(COP([O-])(=O)CC[N+](C)(C)C)COC(=O)CCCCCCCC=CCC=CCCCCC JQWAHKMIYCERGA-UHFFFAOYSA-N 0.000 description 1
- OMDQUFIYNPYJFM-XKDAHURESA-N (2r,3r,4s,5r,6s)-2-(hydroxymethyl)-6-[[(2r,3s,4r,5s,6r)-4,5,6-trihydroxy-3-[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@H](O)[C@H](O)O1 OMDQUFIYNPYJFM-XKDAHURESA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- KILNVBDSWZSGLL-KXQOOQHDSA-N 1,2-dihexadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCC KILNVBDSWZSGLL-KXQOOQHDSA-N 0.000 description 1
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 1
- ZONJATNKKGGVSU-UHFFFAOYSA-N 14-methylpentadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCC(O)=O ZONJATNKKGGVSU-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 229920000298 Cellophane Polymers 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 239000001879 Curdlan Substances 0.000 description 1
- 229920002558 Curdlan Polymers 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 229920000855 Fucoidan Polymers 0.000 description 1
- PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 description 1
- 229920000926 Galactomannan Polymers 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 1
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- 241000446313 Lamella Species 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 239000004976 Lyotropic liquid crystal Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 244000062730 Melissa officinalis Species 0.000 description 1
- 235000010654 Melissa officinalis Nutrition 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 235000021319 Palmitoleic acid Nutrition 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 239000004974 Thermotropic liquid crystal Substances 0.000 description 1
- XKMYWNHZAQUEPY-YZGJEOKZSA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] 12-hydroxyoctadecanoate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCC(O)CCCCCC)C1 XKMYWNHZAQUEPY-YZGJEOKZSA-N 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940092738 beeswax Drugs 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 229940082483 carnauba wax Drugs 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 description 1
- 239000002734 clay mineral Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 235000019316 curdlan Nutrition 0.000 description 1
- 229940078035 curdlan Drugs 0.000 description 1
- 125000005131 dialkylammonium group Chemical group 0.000 description 1
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 1
- BIABMEZBCHDPBV-UHFFFAOYSA-N dipalmitoyl phosphatidylglycerol Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(COP(O)(=O)OCC(O)CO)OC(=O)CCCCCCCCCCCCCCC BIABMEZBCHDPBV-UHFFFAOYSA-N 0.000 description 1
- 239000002612 dispersion medium Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000010492 gellan gum Nutrition 0.000 description 1
- 239000000216 gellan gum Substances 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 229950006191 gluconic acid Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229960001031 glucose Drugs 0.000 description 1
- 125000004395 glucoside group Chemical group 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 229920000578 graft copolymer Polymers 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 239000003676 hair preparation Substances 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- SFFVATKALSIZGN-UHFFFAOYSA-N hexadecan-7-ol Chemical compound CCCCCCCCCC(O)CCCCCC SFFVATKALSIZGN-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 230000005660 hydrophilic surface Effects 0.000 description 1
- 125000001165 hydrophobic group Chemical group 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229920003063 hydroxymethyl cellulose Polymers 0.000 description 1
- 229940031574 hydroxymethyl cellulose Drugs 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229940070765 laurate Drugs 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 229940041290 mannose Drugs 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 229910052901 montmorillonite Inorganic materials 0.000 description 1
- 229940105132 myristate Drugs 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 238000000879 optical micrograph Methods 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 230000010287 polarization Effects 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 description 1
- 239000000770 propane-1,2-diol alginate Substances 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 125000001453 quaternary ammonium group Chemical group 0.000 description 1
- 239000005871 repellent Substances 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- WBHHMMIMDMUBKC-XLNAKTSKSA-N ricinelaidic acid Chemical compound CCCCCC[C@@H](O)C\C=C\CCCCCCCC(O)=O WBHHMMIMDMUBKC-XLNAKTSKSA-N 0.000 description 1
- 229960003656 ricinoleic acid Drugs 0.000 description 1
- FEUQNCSVHBHROZ-UHFFFAOYSA-N ricinoleic acid Natural products CCCCCCC(O[Si](C)(C)C)CC=CCCCCCCCC(=O)OC FEUQNCSVHBHROZ-UHFFFAOYSA-N 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 229940083466 soybean lecithin Drugs 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 125000005207 tetraalkylammonium group Chemical group 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 125000005208 trialkylammonium group Chemical group 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
本発明は、皮膚又は毛髪のための外用剤及び外用剤の製造方法に関する。 The present invention relates to an external preparation for skin or hair and a method for producing the external preparation.
従来、保湿等を目的として皮膚や毛髪に塗布される外用剤として、オイルが使用されている。 Conventionally, oil is used as an external preparation applied to skin and hair for the purpose of moisturizing.
特に、塗布性や使用感に優れることから、近年、皮膚や毛髪に塗布される外用剤としてオイルゲル化粧料(例えば、特許文献1〜3を参照)が、使用されている。 In particular, oil gel cosmetics (see, for example, Patent Documents 1 to 3) have been used as external preparations applied to the skin and hair since they are excellent in applicability and usability.
しかしながら、特許文献1〜3に記載されたような従来のオイルゲルは水分蒸散抑制効果が未だ十分でなく、改善の余地を有する。 However, conventional oil gels such as those described in Patent Documents 1 to 3 are still not sufficiently effective in suppressing moisture transpiration and have room for improvement.
本発明は、以上の実情に鑑みてなされたものであり、水分蒸散抑制効果に優れた外用剤及び外用剤の製造方法を提供することを目的とする。 This invention is made | formed in view of the above situation, and aims at providing the manufacturing method of the external preparation and the external preparation excellent in the moisture transpiration suppression effect.
本発明者らは、リオトロピック球状液晶がオイルゲル中に分散することで、高い水分蒸散抑制効果を得られることを見出し、本発明を完成するに至った。具体的に、本発明は以下のものを提供する。 The present inventors have found that a high moisture transpiration suppressing effect can be obtained by dispersing lyotropic spherical liquid crystals in an oil gel, and have completed the present invention. Specifically, the present invention provides the following.
(1) 抱水性油剤、水、及び両親媒性物質により形成された閉鎖小胞体又は水酸基を有する重縮合ポリマー粒子を含み、
前記抱水性油剤濃度が0.015質量%超であって少なくとも一部がリオトロピック球状液晶状態で連続相としてのオイルゲル中に分散していることを特徴とする外用剤。
(1) including polycondensation polymer particles having closed vesicles or hydroxyl groups formed by a water-containing oil, water, and an amphiphile;
An external preparation characterized in that the concentration of the hydrated oil is greater than 0.015% by mass and at least a part of the hydrated oil is dispersed in an oil gel as a continuous phase in a lyotropic spherical liquid crystal state.
(2) 外用剤の製造方法であって、
両親媒性物質が水相で形成する閉鎖小胞体、又は水酸基を有する重縮合ポリマー粒子、で構成された乳化剤によって抱水性油剤を水相に乳化分散したO/W型乳化液を、連続相としてのオイルゲル中に分散する工程を含み、
前記抱水性油剤の少なくとも一部がリオトロピック球状液晶を形成し、
前記抱水性油剤の配合量は、前記外用剤に対し0.015質量%以上である方法。
(2) A method for producing an external preparation,
An O / W emulsion obtained by emulsifying and dispersing a water-containing oil in an aqueous phase with an emulsifier composed of closed endoplasmic reticulum formed by an amphiphilic substance in an aqueous phase or polycondensation polymer particles having a hydroxyl group, as a continuous phase A step of dispersing in an oil gel of
At least a portion of the hydrated oil forms a lyotropic spherical liquid crystal;
The amount of the hydrated oil is 0.015% by mass or more based on the external preparation.
本発明によれば、水分蒸散抑制効果に優れた外用剤及び外用剤の製造方法を提供することができる。 ADVANTAGE OF THE INVENTION According to this invention, the manufacturing method of the external preparation and the external preparation excellent in the moisture transpiration suppression effect can be provided.
以下、本発明の実施形態を説明するが、これらに本発明が限定されるものではない。 Hereinafter, although embodiment of this invention is described, this invention is not limited to these.
<外用剤>
本発明の外用剤は、抱水性油剤、水、及び両親媒性物質により形成された閉鎖小胞体又は水酸基を有する重縮合ポリマー粒子を含み、抱水性油剤濃度が0.015質量%超であって少なくとも一部がリオトロピック球状液晶状態で連続相としてのオイルゲル中に分散していることを特徴とする。これにより、外用剤は良好な水分蒸散抑制効果を奏する。また、本発明の外用剤は、肌への付着性が良好であり、べたつきにくく、密着性が良好である。また、本発明の外用剤は、硬度、密着性が良好であることから、被膜感が良好であり、さらに、ツヤ持続性、しわ改善効果、しっとり感、なじませやすさ、ふっくら感に優れ、高い保湿効果を奏する。本発明において、水分蒸散抑制効果を奏する理由は、以下のとおりと推測される。
<External preparation>
The external preparation of the present invention comprises polycondensation polymer particles having closed vesicles or hydroxyl groups formed by a water-containing oil agent, water, and an amphiphile, and the water-holding oil agent concentration is more than 0.015% by mass. At least a portion is dispersed in an oil gel as a continuous phase in a lyotropic spherical liquid crystal state. Thereby, an external preparation has a favorable moisture evaporation suppression effect. Moreover, the external preparation of this invention has favorable adhesiveness to skin, it is hard to stick, and adhesiveness is favorable. In addition, the external preparation of the present invention has a good film feeling because of its good hardness and adhesion, and further has excellent gloss durability, wrinkle improvement effect, moist feeling, ease of conformation, and plump feeling. High moisturizing effect. In the present invention, the reason for the effect of suppressing moisture transpiration is presumed as follows.
上述の従来のオイルゲルは、皮膚や毛髪を覆うことで、皮膚や毛髪からの水の蒸散を抑制効果が認められたものの、皮膚や毛髪における複雑な細かい凹凸からの蒸散を十分に抑制することができなかった。これに対し、本発明のオイルゲルは、リオトロピック球状液晶をオイルゲル中に連続相として分散することで、製剤の皮膚や毛髪への密着性を高め、かつ液晶構造の水の往来を平衡状態に保持する性質により、皮膚や毛髪における複雑な細かい凹凸からの水分の蒸散を十分に抑制する効果を得られる。 Although the above-mentioned conventional oil gel has an effect of suppressing the transpiration of water from the skin and hair by covering the skin and hair, it can sufficiently suppress the transpiration from complex fine irregularities in the skin and hair. could not. In contrast, the oil gel of the present invention disperses the lyotropic spherical liquid crystal as a continuous phase in the oil gel, thereby improving the adhesion of the preparation to the skin and hair and maintaining the water flow of the liquid crystal structure in an equilibrium state. Depending on the nature, it is possible to obtain an effect of sufficiently suppressing the transpiration of water from complex fine irregularities in the skin and hair.
本発明の「外用剤」とは、皮膚又は毛髪の外用剤のことを指す。 The “external preparation” of the present invention refers to an external preparation for skin or hair.
本発明において、リオトロピック球状液晶とは、ラメラ液晶の球状の層が重なったものである。リオトロピック球状液晶は、乳化物の全光顕微鏡写真で観察される内相(抱水性油剤を含む相)の形状が実質的に円形(正円、楕円、それに近似した形状)であり、偏光顕微鏡写真で対応する内相(抱水性油剤を含む油相)に黒十字ニコルが確認されることで特定される。リオトロピック球状液晶は、従来知られるサーモトロピック液晶の球晶(偏光顕微鏡写真での黒十字ニコルは、液晶の方向と偏光の照射方向とが偶然に所定関係になった内相(抱水性油剤を含む油相)のみに観察され、その確率はリオトロピック球状液晶に比べ有意に低い)とは明確に異なる。なお、以下、本発明において、抱水性油剤を含む油相を、「抱水性油剤相」と呼称する場合があり、オイルゲルを含む油相(以下、「オイルゲル相」と呼称する場合がある。)と区別する。 In the present invention, the lyotropic spherical liquid crystal is obtained by overlapping spherical layers of lamellar liquid crystal. In the lyotropic spherical liquid crystal, the shape of the internal phase (phase containing a water-containing oil agent) observed in the all-optical micrograph of the emulsion is substantially circular (a perfect circle, an ellipse, or a shape close to it), and a polarizing micrograph The black cross Nicole is identified in the corresponding internal phase (oil phase containing a water-containing oil agent). The lyotropic spherical liquid crystal is a conventionally known thermotropic liquid crystal spherulite (the black crossed Nicol in the polarization micrograph shows an internal phase (including a water-containing oil agent) in which the direction of the liquid crystal and the direction of irradiation of the polarized light have a predetermined relationship. Observed only in the oil phase), the probability is significantly different from that in the lyotropic spherical liquid crystal). Hereinafter, in the present invention, an oil phase containing a water-holding oil agent may be referred to as a “water-holding oil agent phase”, and an oil phase containing an oil gel (hereinafter also referred to as “oil-gel phase”). To distinguish.
本発明の外用剤においては、抱水性油剤の少なくとも一部がリオトロピック球状液晶状態で連続相としてのオイルゲル中に分散している状態であればよく、すべての抱水性油剤がリオトロピック球状液晶状態でなくてもよい。また、リオトロピック球状液晶の少なくとも一部が連続相のオイルゲル中に分散していればよく、すべてのリオトロピック球状液晶が連続相のオイルゲル中に分散していなくてもよい。ただし、上記効果を十分に得られやすい点で、1.0μm以上の断面長径を有する抱水性油剤相であってもよい。なお、ここでいう「1.0μm以上の断面長径」は、全光顕微鏡の視野における抱水性油剤相の断面長径を指す。後述のとおり、粒子径が過小の油相は可視光下での干渉光による白色発光ができないため、このような油相を含まない母集団におけるリオトロピック球状液晶の状態の油相の割合の方が、外用剤の性能を高精度に反映したものになる。 In the external preparation of the present invention, it is sufficient that at least a part of the hydrated oil agent is dispersed in the oil gel as the continuous phase in the lyotropic spherical liquid crystal state, and all the hydrated oil agents are not in the lyotropic spherical liquid crystal state. May be. Further, it is sufficient that at least a part of the lyotropic spherical liquid crystal is dispersed in the oil gel of the continuous phase, and not all the lyotropic spherical liquid crystals may be dispersed in the oil gel of the continuous phase. However, it may be a hydrated oil phase having a cross-sectional major axis of 1.0 μm or more in that the above effect can be sufficiently obtained. In addition, "cross-sectional major axis of 1.0 micrometer or more" here refers to the cross-sectional major axis of the hydrated oil agent phase in the visual field of an all-optical microscope. As will be described later, since the oil phase with an excessively small particle size cannot emit white light due to interference light under visible light, the proportion of the oil phase in the lyotropic spherical liquid crystal state in the population that does not include such an oil phase is better. It will reflect the performance of the external preparation with high accuracy.
本発明における外用剤は、まず、リオトロピック球状液晶である抱水性油剤と水とによりO/W型エマルションを形成し、該O/W型エマルションをオイルゲル中に分散することで形成することができる。 The external preparation in the present invention can be formed by first forming an O / W emulsion with a water-holding oil agent which is a lyotropic spherical liquid crystal and water, and dispersing the O / W emulsion in an oil gel.
リオトロピック球状液晶の粒子径が大きくなることで、リオトロピック球状液晶が塗布時に壊れやすくなり、抱水性油剤が均一に塗布対象に広がりやすくなり、皮膚や毛髪における細かい凹凸を十分に塞ぎやすくなり、その結果、高い水分蒸散抑制効果を得やすくなる。そこで、リオトロピック球状液晶の平均粒子径が1.0μm以上であることが好ましく、より好ましくは3.0μm以上、最も好ましくは5.0μm以上である。これにより、高い水分蒸散効果を得られるため、上記の特性(特に、硬度、密着性、被膜感、ツヤ持続性、しわ改善効果、しっとり感、なじませやすさ、ふっくら感、保湿効果等)がより向上する。また、製造の容易さと上記効果とのバランスの観点から、リオトロピック球状液晶の平均粒子径は、特に限定されないが、20μm以下、15μm以下、10μm以下であってよい。抱水性油剤相の平均粒子径は、外用剤の粘度が十分に低い(必要に応じ、希釈する)状態で、レーザー回折散乱式粒度分布計(島津製作所 SALD2100)により測定される。 By increasing the particle size of the lyotropic spherical liquid crystal, the lyotropic spherical liquid crystal becomes fragile when applied, and the water hydrated oil agent tends to spread evenly on the application target, making it easy to sufficiently close fine irregularities on the skin and hair. It becomes easy to obtain a high moisture transpiration suppression effect. Therefore, the average particle diameter of the lyotropic spherical liquid crystal is preferably 1.0 μm or more, more preferably 3.0 μm or more, and most preferably 5.0 μm or more. As a result, a high moisture transpiration effect can be obtained, so that the above characteristics (particularly hardness, adhesion, coating feeling, gloss persistence, wrinkle improvement effect, moist feeling, ease of fitting, plump feeling, moisturizing effect, etc.) More improved. Further, from the viewpoint of balance between ease of production and the above effect, the average particle diameter of the lyotropic spherical liquid crystal is not particularly limited, but may be 20 μm or less, 15 μm or less, and 10 μm or less. The average particle diameter of the water hydrated oil phase is measured by a laser diffraction / scattering particle size distribution analyzer (SALD2100, Shimadzu Corporation) in a state where the viscosity of the external preparation is sufficiently low (diluted if necessary).
抱水性油剤は、特に限定されないが、分子内に1以上の極性基を有し、常温で液体もしくはペースト状や固体の油溶性物質のいずれも用いる事ができ、このように、抱水性油剤相の状態にかかわらず、水分蒸散抑制効果を得られる点で有用である。抱水性油剤としては、例えば、イソステアリン酸、イソパルミチン酸、オレイン酸、パルミトレイン酸、リノール酸、リシノレイン酸等の脂肪酸、ラノリン、ラノリンアルコール、水素添加ラノリンアルコール等のラノリン誘導体、セタノール、ヘキシルデカノール、イソステアリルアルコール、ステアリルアルコール、オクチルドデカノール、オレイルアルコール、セトステアリルアルコール、ベヘニルアルコール、水添ナタネ油アルコール等の高級アルコール、コレステロール誘導体及びフィトステロール誘導体等の動植物油由来の脂肪酸エステル及び脂肪酸オリゴマーエステル、ミリスチン酸オクチルドデシル等が挙げられ、これらの1種又は2種以上であってよい。前記コレステロール誘導体及びフィトステロール誘導体としては、マカデミアナッツ油脂肪酸コレステリル、マカデミアナッツ油脂肪酸フィトステリル、ラノリン脂肪酸コレステリル、12−ヒドロキシステアリン酸コレステリル等が挙げられる。中でも、リオトロピック球状液晶を形成しやすい観点から、高級アルコールを用いることが特に好ましい。 Although the water-holding oil is not particularly limited, any oil-soluble substance that has one or more polar groups in the molecule and is liquid or pasty or solid at room temperature can be used. Regardless of the state, it is useful in that it can provide an effect of suppressing moisture transpiration. Examples of the water-holding oil include fatty acids such as isostearic acid, isopalmitic acid, oleic acid, palmitoleic acid, linoleic acid, ricinoleic acid, lanolin derivatives such as lanolin, lanolin alcohol, hydrogenated lanolin alcohol, cetanol, hexyldecanol, isostearyl. Alcohol, stearyl alcohol, octyldodecanol, oleyl alcohol, cetostearyl alcohol, behenyl alcohol, fatty alcohol esters and fatty acid oligomers derived from animal and vegetable oils such as cholesterol derivatives and phytosterol derivatives, octyldodecyl myristate Etc., and may be one or more of these. Examples of the cholesterol derivative and phytosterol derivative include macadamia nut oil fatty acid cholesteryl, macadamia nut oil fatty acid phytosteryl, lanolin fatty acid cholesteryl, and cholesteryl 12-hydroxystearate. Of these, higher alcohols are particularly preferred from the viewpoint of easily forming lyotropic spherical liquid crystals.
本発明の外用剤は、抱水性油剤の配合量が外用剤に対して0.015質量%超である。抱水性油剤によるリオトロピック球状液晶が所望の上記特性を与えることから、抱水性油剤の配合量は十分に多いことが好ましい。本発明の外用剤では、抱水性油剤の固化が高度に抑制されることから、抱水性油剤の配合量を十分に多くすることができ、外用剤に対し0.02質量%以上、0.03質量%以上、0.04質量%以上、0.05質量%以上、0.06質量%以上、0.07質量%以上、0.08質量%以上、0.09質量%以上、0.1質量%以上、0.2質量%以上、0.3質量%以上、0.4質量%以上、0.5質量%以上であることが好ましい。他方、抱水性油剤の配合量の上限は、外用剤に対し、40質量%以下、30質量%以下、20質量%以下、15質量%以下、10質量%以下、5.0質量%以下、3.0質量%以下、1.0質量%以下等であってもよい。なお、本発明における各配合量は、実際に配合した量、又はガスクロマトグラフィにより測定される含有量である。 As for the external preparation of this invention, the compounding quantity of a water-holding oil agent is more than 0.015 mass% with respect to an external preparation. Since the lyotropic spherical liquid crystal based on the water-repellent oil gives the desired properties, it is preferable that the amount of the water-hydrate oil is sufficiently large. In the external preparation of the present invention, the solidification of the water hydrated oil is highly suppressed, so that the amount of the water hydrated oil can be sufficiently increased, and is 0.02% by mass or more, 0.03% with respect to the external preparation. Mass% or more, 0.04 mass% or more, 0.05 mass% or more, 0.06 mass% or more, 0.07 mass% or more, 0.08 mass% or more, 0.09 mass% or more, 0.1 mass% % Or more, 0.2 mass% or more, 0.3 mass% or more, 0.4 mass% or more, and 0.5 mass% or more are preferable. On the other hand, the upper limit of the amount of the hydrated oil is 40% by mass or less, 30% by mass or less, 20% by mass or less, 15% by mass or less, 10% by mass or less, 5.0% by mass or less with respect to the external preparation. 0.0 mass% or less, 1.0 mass% or less, etc. may be sufficient. In addition, each compounding quantity in this invention is the content measured by the quantity which actually mix | blended or gas chromatography.
抱水性油剤相は、乳化物に求められる性能に応じ、抱水性油剤以外の油を含んでもよい。ただし、本発明では、前述のように抱水性油剤の固化が抑制されるため、液状油成分(例えば、ミネラルオイル)を抱水性油剤の固化を抑制するために抱水性油剤相としては用いる必要はない。 The hydrated oil phase may contain an oil other than the hydrated oil depending on the performance required for the emulsion. However, in the present invention, since the solidification of the hydrated oil is suppressed as described above, it is necessary to use a liquid oil component (for example, mineral oil) as the hydrated oil phase in order to suppress the solidification of the hydrated oil. Absent.
本発明に含まれる水は、リオトロピック球状液晶である抱水性油剤とO/W型エマルションを形成する際に用いられるものである。水の含有量は、特に限定されないが、相対的に抱水性油剤相又はオイルゲル相の含有量が多くなり、高い水分蒸散抑制効果を得られ、また、硬度を抑えて高い被膜感を得られることから、外用剤に対して、15質量%以下、10質量%以下、5質量%以下、3質量%以下、1質量%以下であることが好ましい。他方、保湿効果を得られる観点で、例えば、0.001質量%以上、0.01質量%以上、0.05質量%以上、0.1質量%以上、0.5質量%以上であることが好ましい。 The water contained in the present invention is used when forming an O / W emulsion with a water-holding oil that is a lyotropic spherical liquid crystal. The water content is not particularly limited, but the content of the water hydrated oil phase or oil gel phase is relatively increased, a high moisture transpiration suppression effect can be obtained, and a high film feeling can be obtained by suppressing the hardness. Therefore, the content is preferably 15% by mass or less, 10% by mass or less, 5% by mass or less, 3% by mass or less, and 1% by mass or less with respect to the external preparation. On the other hand, from the viewpoint of obtaining a moisturizing effect, for example, 0.001% by mass or more, 0.01% by mass or more, 0.05% by mass or more, 0.1% by mass or more, 0.5% by mass or more. preferable.
本発明におけるオイルゲルとは、親油性のオイルゲル化剤で増粘されたゲル状のオイル(油成分)のことを指し、例えば、オイルにオイルゲル化剤を添加することで、調製することができる。オイルゲルに用いられるオイルとしては、例えば、鉱物油類(ミネラルオイル等)、動植物油、炭化水素油、脂肪酸エステル類等の液状油、ワックス類(ミツロウ、キャンデリラロウ、カルナバロウ、ラノリン等の天然ワックスエステル、マイクロクリスタリンワックス、パラフィンワックス等の合成ワックス)等の半固形もしくは固形の油が挙げられる。 The oil gel in the present invention refers to a gel-like oil (oil component) thickened with a lipophilic oil gelling agent, and can be prepared by adding an oil gelling agent to oil, for example. Examples of the oil used in the oil gel include liquid oils such as mineral oils (mineral oils), animal and vegetable oils, hydrocarbon oils, fatty acid esters, and waxes (natural waxes such as beeswax, candelilla wax, carnauba wax, lanolin). Semi-solid or solid oils such as esters, microcrystalline waxes, synthetic waxes such as paraffin wax).
オイルゲルのオイルの含有量は、特に限定されないが、油の量が多くなり、水の蒸散抑制効果が高くなる点で、外用剤に対して、40質量%以上、50質量%以上、60質量%以上、70質量%以上、80質量%以上、90質量%以上であることが好ましい。他方、オイルゲルのオイルの含有量の上限は、外用剤に対して、98質量%以下、97質量%以下、96質量%以下、95質量%以下等であってもよい。 The oil content of the oil gel is not particularly limited, but is 40% by mass or more, 50% by mass or more, and 60% by mass with respect to the external preparation in that the amount of oil increases and the effect of suppressing water transpiration increases. As mentioned above, it is preferable that they are 70 mass% or more, 80 mass% or more, and 90 mass% or more. On the other hand, the upper limit of the oil content of the oil gel may be 98% by mass or less, 97% by mass or less, 96% by mass or less, 95% by mass or less, etc. with respect to the external preparation.
オイルゲル化剤とは、オイルを増粘させる物質のことを指す。オイルゲル化剤としては、公知のものを使用することができ、例えば、デキストリン脂肪酸エステル、グリセリン脂肪酸エステル、プルラン脂肪酸エステル、有機変性粘土鉱(モンモリロナイト等の粘土鉱物を第4級アンモニウム処理した有機変性粘土鉱物)、微粒子シリカ等が挙げられる。デキストリン脂肪酸エステルとしては、デキストリンと炭素数8〜22の高級脂肪酸とのエステルが例示され、具体的には、パルミチン酸デキストリン、エチルヘキサン酸デキストリン、ラウリン酸デキストリン、ミリスチン酸デキストリン、ステアリン酸デキストリン、ベヘニン酸デキストリン等が挙げられる。 The oil gelling agent refers to a substance that thickens oil. As the oil gelling agent, known ones can be used, for example, dextrin fatty acid ester, glycerin fatty acid ester, pullulan fatty acid ester, organic modified clay ore (organic modified clay obtained by treating quaternary ammonium with clay mineral such as montmorillonite. Mineral), fine particle silica and the like. Examples of the dextrin fatty acid ester include esters of dextrin and higher fatty acids having 8 to 22 carbon atoms, specifically, dextrin palmitate, dextrin ethylhexanoate, dextrin laurate, dextrin myristate, dextrin stearate, behenine Acid dextrin etc. are mentioned.
抱水性油剤は液晶構造をとる性質を有するが、水に接触すると、やがて固化して液晶構造をとれない場合がある。しかし、本発明では、オイルゲル中に、閉鎖小胞体又は重縮合ポリマーの粒子を含むことで、水と混合された抱水性油剤の室温(具体的には25℃)での固化を抑制して流動状態を実現し、これにより液晶状態を実現させ、また、その過程でファンデルワールス力により抱水性油剤を球状に乳化させるため、リオトロピック球状液晶を形成することができる。この作用効果は、閉鎖小胞体又は重縮合ポリマーの粒子による三相乳化に特有のものであり、従来の界面活性剤では得られないものである。この観点で、本発明の外用剤において、両親媒性物質により形成された閉鎖小胞体及び/又は水酸基を有する重縮合ポリマー粒子を含有する。両親媒性物質により形成された閉鎖小胞体又は水酸基を有する重縮合ポリマー粒子は、表面が親水性の粒子であり、例えば、ファンデルワールス力によって水相中の油相との界面に介在することで、乳化状態を維持してもよい。この状態は、乳化物を透過型電子顕微鏡(TEM)で観察することで確認される(例えば、特許第3855203号公報)。なお、閉鎖小胞体又は水酸基を有する重縮合ポリマー粒子による乳化機構は、三相乳化機構として公知であり、界面活性剤による乳化機構、すなわち親水性部分及び疎水性部分をそれぞれ水相及び油相に向け、油水界面張力を下げることで乳化状態を維持する乳化機構とは全く異なる(例えば特許3855203号公報参照)。 The water-holding oil has a property of taking a liquid crystal structure, but when it comes into contact with water, it may solidify soon and not take a liquid crystal structure. However, in the present invention, the inclusion of particles of closed vesicles or polycondensation polymer in the oil gel suppresses solidification of the water-containing oil mixed with water at room temperature (specifically, 25 ° C.) and flows. The liquid crystal state is realized by realizing the state, and the hydrated oil agent is spherically emulsified by van der Waals force in the process, so that the lyotropic spherical liquid crystal can be formed. This effect is unique to three-phase emulsification with closed endoplasmic reticulum or polycondensation polymer particles and cannot be obtained with conventional surfactants. From this viewpoint, the external preparation of the present invention contains polycondensation polymer particles having closed vesicles and / or hydroxyl groups formed of an amphiphilic substance. The polycondensation polymer particles having closed vesicles or hydroxyl groups formed of amphiphiles are particles having hydrophilic surfaces, for example, intervening at the interface with the oil phase in the aqueous phase by van der Waals force. Thus, the emulsified state may be maintained. This state is confirmed by observing the emulsion with a transmission electron microscope (TEM) (for example, Japanese Patent No. 3855203). Incidentally, the emulsification mechanism by the closed condensation endoplasmic reticulum or the polycondensation polymer particles having a hydroxyl group is known as a three-phase emulsification mechanism, and the emulsification mechanism by the surfactant, that is, the hydrophilic part and the hydrophobic part are converted into an aqueous phase and an oil phase, respectively. And an emulsification mechanism that maintains the emulsified state by lowering the oil-water interface tension (see, for example, Japanese Patent No. 3855203).
閉鎖小胞体を形成する両親媒性物質としては、特に限定されないが、下記の一般式1で表されるポリオキシエチレン硬化ひまし油の誘導体、もしくは一般式2で表されるジアルキルアンモニウム誘導体、トリアルキルアンモニウム誘導体、テトラアルキルアンモニウム誘導体、ジアルケニルアンモニウム誘導体、トリアルケニルアンモニウム誘導体、又はテトラアルケニルアンモニウム誘導体のハロゲン塩の誘導体が挙げられる。 The amphiphile that forms the closed endoplasmic reticulum is not particularly limited, but is a polyoxyethylene hydrogenated castor oil derivative represented by the following general formula 1, a dialkylammonium derivative represented by the general formula 2, or a trialkylammonium Derivatives, tetraalkylammonium derivatives, dialkenylammonium derivatives, trialkenylammonium derivatives, or derivatives of halogen salts of tetraalkenylammonium derivatives.
一般式1
式中、エチレンオキシドの平均付加モル数であるEは、3〜100である。Eが過大になると、両親媒性物質を溶解する良溶媒の種類が制限されるため、親水性ナノ粒子の製造の自由度が狭まる。Eの上限は好ましくは50であり、より好ましくは40であり、Eの下限は好ましくは5である。 In the formula, E, which is the average added mole number of ethylene oxide, is 3 to 100. If E is excessive, the type of good solvent that dissolves the amphiphilic substance is limited, and thus the degree of freedom in producing hydrophilic nanoparticles is narrowed. The upper limit of E is preferably 50, more preferably 40, and the lower limit of E is preferably 5.
一般式2
式中、R1及びR2は、各々独立して炭素数8〜22のアルキル基又はアルケニル基であり、R3及びR4は、各々独立して水素又は炭素数1〜4のアルキル基であり、XはF、Cl、Br、I又はCH3COOである。 In the formula, R 1 and R 2 are each independently an alkyl group or alkenyl group having 8 to 22 carbon atoms, R 3 and R 4 are each independently hydrogen or an alkyl group having 1 to 4 carbon atoms, and X is F, Cl, Br, I or CH 3 COO.
両親媒性物質としては、リン脂質やリン脂質誘導体等、特に疎水基と親水基とがエステル結合したものを採用してもよい。また、刺激緩和性に優れる点で、ジラウロイルグルタミン酸リシンNaも好ましい。 As the amphiphile, phospholipids, phospholipid derivatives, etc., in particular, those in which a hydrophobic group and a hydrophilic group are ester-bonded may be employed. Moreover, dilauroyl glutamic acid lysine Na is also preferable in terms of excellent stimulus relaxation properties.
リン脂質としては、下記の一般式3で示される構成のうち、炭素鎖長12のDLPC(1,2−Dilauroyl−sn−glycero−3−phospho−rac−1−choline)、炭素鎖長14のDMPC(1,2−Dimyristoyl−sn−glycero−3−phospho−rac−1−choline)、炭素鎖長16のDPPC(1,2−Dipalmitoyl−sn−glycero−3−phospho−rac−1−choline)が採用可能である。 As the phospholipid, among the structures represented by the following general formula 3, DLPC (1,2-Dilauroyl-sn-glycero-3-phospho-rac-1-choline) having a carbon chain length of 12, DMPC (1,2-Dimyristol-sn-glycero-3-phospho-rac-1-choline), DPPC with a carbon chain length of 16 (1,2-Dipalmitoyyl-sn-glycero-3-phospho-rac-1-choline) Can be adopted.
一般式3
また、下記の一般式4で示される構成のうち、炭素鎖長12のDLPG(1,2−Dilauroyl−sn−glycero−3−phospho−rac−1−glycerol)のNa塩又はNH4塩、炭素鎖長14のDMPG(1,2−Dimyristoyl−sn−glycero−3−phospho−rac−1−glycerol)のNa塩又はNH4塩、炭素鎖長16のDPPG(1,2−Dipalmitoyl−sn−glycero−3−phospho−rac−1−glycerol)のNa塩又はNH4塩を採用してもよい。 In addition, among the structures represented by the following general formula 4, DLPG (1,2-Diilauroyl-sn-glycero-3-phospho-rac-1-glycerol) Na salt or NH 4 salt of carbon chain length 12 and carbon NaPG or NH4 salt of DMPG (1,2-Dimyristol-sn-glycero-3-phospho-1-rac-1-glycerol) having a chain length of 14, DPPG (1,2-Dipalmitoyyl-sn-glycero-) having a carbon chain length of 16 3-phospho-rac-1-glycerol) Na salt or NH 4 salt may be employed.
一般式4
さらに、両親媒性物質におけるリン脂質として卵黄レシチン又は大豆レシチン、分別レシチン、リゾレシチン等のレシチン又はそれを水素化したものを採用してもよい。これらのうち、リゾレシチン、分別レシチンが好ましい。 Furthermore, lecithin such as egg yolk lecithin, soybean lecithin, fractionated lecithin, lysolecithin or the like obtained by hydrogenation thereof may be employed as the phospholipid in the amphiphile. Of these, lysolecithin and fractionated lecithin are preferred.
水酸基を有する重縮合ポリマーは、天然高分子又は合成高分子のいずれであってもよく、乳化剤の用途に応じて適宜選択されてよい。ただし、安全性に優れ、一般的に安価である点で、天然高分子が好ましく、乳化機能に優れる点で以下に述べる糖ポリマーがより好ましい。なお、粒子とは、重縮合ポリマーが単粒子したもの、又はその単粒子同士が連なったもののいずれも包含する一方、単粒子化される前の凝集体(網目構造を有する)は包含しない。 The polycondensation polymer having a hydroxyl group may be either a natural polymer or a synthetic polymer, and may be appropriately selected according to the use of the emulsifier. However, natural polymers are preferable from the viewpoint of safety and generally inexpensive, and sugar polymers described below are more preferable from the viewpoint of excellent emulsifying function. The particles include both single particles of the polycondensation polymer and those in which the single particles are connected, but do not include aggregates (having a network structure) before being formed into single particles.
糖ポリマーは、セルロース、デンプン等のグルコシド構造を有するポリマーである。例えば、リボース、キシロース、ラムノース、フコース、グルコース、マンノース、グルクロン酸、グルコン酸等の単糖類の中からいくつかの糖を構成要素として微生物が産生するもの、キサンタンガム、アラビアゴム、グアーガム、カラヤガム、カラギーナン、ペクチン、フコイダン、クインシードガム、トラントガム、ローカストビーンガム、ガラクトマンナン、カードラン、ジェランガム、フコゲル、カゼイン、ゼラチン、デンプン、コラーゲン等の天然高分子、メチルセルロース、エチルセルロース、メチルヒドロキシプロピルセルロース、カルボキシメチルセルロース、ヒドロキシメチルセルロース、ヒドロキシプロピルセルロース、カルボキシメチルセルロースナトリウム、アルギン酸プロピレングリコールエステル、セルロース結晶体、デンプン・アクリル酸ナトリウムグラフト重合体、疎水化ヒドロキシプロピルメチルセルロース、ステアロキシPGヒドロキシエチルセルローススルホン酸Na等のスルホン化セルロース誘導体等の半合成高分子等が挙げられる。また、糖ポリマー以外の水酸基を有する重縮合ポリマーとしては、ポリビニルアルコール、ポリビニルピロリドン、カルボキシビニルポリマー、ポリアクリル酸塩、ポリエチレンオキシド等の合成高分子が挙げられる。 The sugar polymer is a polymer having a glucoside structure such as cellulose and starch. For example, those produced by microorganisms with some sugars among monosaccharides such as ribose, xylose, rhamnose, fucose, glucose, mannose, glucuronic acid, gluconic acid, xanthan gum, gum arabic, guar gum, caraya gum, carrageenan , Pectin, fucoidan, quinseed gum, tranto gum, locust bean gum, galactomannan, curdlan, gellan gum, fucogel, casein, gelatin, starch, collagen and other natural polymers, methylcellulose, ethylcellulose, methylhydroxypropylcellulose, carboxymethylcellulose, Hydroxymethylcellulose, hydroxypropylcellulose, sodium carboxymethylcellulose, propylene glycol alginate, cellulose Crystals, starch-acrylic acid sodium graft polymer, hydrophobic hydroxypropylmethylcellulose, semi-synthetic polymers and the like, such as sulfonated cellulose derivatives such as stearoxy PG hydroxyethylcellulose sulfonic acid Na. In addition, examples of the polycondensation polymer having a hydroxyl group other than a sugar polymer include synthetic polymers such as polyvinyl alcohol, polyvinyl pyrrolidone, carboxyvinyl polymer, polyacrylate, and polyethylene oxide.
閉鎖小胞体及び水酸基を有する重縮合ポリマー粒子は、エマルション形成前では平均粒子径8nm〜800nm程度であるが、O/Wエマルション構造(すなわち、リオトロピック球状液状形成時)においては平均粒子径8nm〜500nm程度である。なお、両親媒性物質の閉鎖小胞体及び水酸基を有する重縮合ポリマーの粒子は、一方のみが含まれても、双方が含まれてもよい。双方が含まれる場合には、例えば、別々に乳化したエマルションを混合してよい。 The polycondensation polymer particles having closed vesicles and hydroxyl groups have an average particle diameter of about 8 nm to 800 nm before the formation of the emulsion, but an average particle diameter of 8 nm to 500 nm in the O / W emulsion structure (that is, when forming a lyotropic spherical liquid). Degree. In addition, the particle | grains of the polycondensation polymer which have the closed endoplasmic reticulum of an amphiphile and a hydroxyl group may contain only one, or both. When both are included, for example, separately emulsified emulsions may be mixed.
本発明における外用剤(水相、抱水性油剤相、又はオイルゲル相)は、その他、外用剤において使用し得る任意の成分を含んでもよい。例えば、本発明の外用剤は、防腐剤、着色剤、pH調整剤等の成分を含んでもよい。また、例えば、本発明の外用剤は界面活性剤を含んでもよいが、含まない方が好ましい。界面活性剤を含む場合、外用剤に対して、界面活性剤の含有量が1.0質量%以下、0.1質量%以下、0.01質量%以下であることが好ましい。 The external preparation (aqueous phase, hydrated oil phase, or oil gel phase) in the present invention may contain any other component that can be used in the external preparation. For example, the external preparation of the present invention may contain components such as a preservative, a colorant, and a pH adjuster. Further, for example, the external preparation of the present invention may contain a surfactant, but it is preferable not to contain it. When the surfactant is included, the content of the surfactant is preferably 1.0% by mass or less, 0.1% by mass or less, and 0.01% by mass or less with respect to the external preparation.
また、本発明の外用剤は、ヒアルロン酸又はその塩を含まなくても高い水分蒸散抑制効果を得られる。この観点で、本発明の外用剤はヒアルロン酸又はその塩の含有量が少なくてもよく、例えば、ヒアルロン酸又はその塩の含有量が外用剤に対して1.0質量%以下、0.5質量%以下、0.1質量%以下、0.01質量%以下等であってもよい。また、本発明の外用剤は、ヒアルロン酸又はその塩を含まなくてもよい。 Moreover, even if the external preparation of this invention does not contain hyaluronic acid or its salt, the high moisture transpiration suppression effect can be acquired. In this respect, the external preparation of the present invention may have a low content of hyaluronic acid or a salt thereof. For example, the content of hyaluronic acid or a salt thereof is 1.0% by mass or less, 0.5% It may be not more than mass%, not more than 0.1 mass%, not more than 0.01 mass%, etc. Moreover, the external preparation of this invention does not need to contain hyaluronic acid or its salt.
本発明の外用剤は、両親媒性物質が水相で形成する閉鎖小胞体、又は水酸基を有する重縮合ポリマー粒子、で構成された乳化剤によって抱水性油剤を水相に乳化分散したO/W型乳化液を、連続相としてのオイルゲル中に分散する工程を含み、抱水性油剤の少なくとも一部がリオトロピック球状液晶を形成し、抱水性油剤の配合量は、外用剤に対し0.015質量%以上である方法により、上述の外用剤を製造することができる。より具体的には、例えば、両親媒性物質の二分子膜の層状体を水に分散させ、又は水酸基を有する重縮合ポリマーを水中に単粒子化させ、両親媒性物質により形成された閉鎖小胞体又は重縮合ポリマーの粒子を含む乳化剤分散液を形成する工程と、乳化剤分散液と、抱水性油剤を含む油剤とを、抱水性油剤の融点以上の温度にて混合することで、O/Wエマルションを形成する工程と、O/Wエマルションをオイルゲル中に分散させる工程と、を有する方法により製造される。 The external preparation of the present invention is an O / W type in which a water-containing oil is emulsified and dispersed in an aqueous phase by an emulsifier composed of closed vesicles formed by an amphiphilic substance in an aqueous phase or polycondensation polymer particles having a hydroxyl group. Including a step of dispersing the emulsified liquid in an oil gel as a continuous phase, wherein at least part of the hydrated oil agent forms a lyotropic spherical liquid crystal, and the blending amount of the hydrated oil agent is 0.015% by mass or more based on the external preparation By the method which is, the above-mentioned external preparation can be manufactured. More specifically, for example, a closed layer formed of an amphiphilic substance is formed by dispersing a layered body of a bilayer film of an amphiphilic substance in water or by making a polycondensation polymer having a hydroxyl group into water into single particles. By mixing the emulsifier dispersion containing particles of the vesicles or polycondensation polymer, the emulsifier dispersion, and the oil containing the water hydrated oil at a temperature equal to or higher than the melting point of the water hydrated oil, O / W It is produced by a method having a step of forming an emulsion and a step of dispersing an O / W emulsion in an oil gel.
閉鎖小胞体又は重縮合ポリマーの粒子を十分に形成することで、十分な粒子径を有する、リオトロピック球状液晶の状態である抱水性油剤相が得られる。このような方法としては、上記の両親媒性物質及び/又は水酸基を有する重縮合ポリマーを分散媒(つまり水)中に添加して長時間に亘って撹拌する、両親媒性物質又は重縮合ポリマーの粒子を良溶媒に溶解した後、その溶液を水と混合する等が挙げられる(例えば、特開2006−241424号公報参照)。これにより、前述の水分蒸散抑制効果がより向上する。具体的に、上記工程は、乳化剤分散液中の閉鎖小胞体又は重縮合ポリマーの粒子が8nm以上800nm以下の平均粒子径を示すまで行うことが好ましい。 By sufficiently forming closed vesicles or polycondensation polymer particles, a hydrated oil phase in a lyotropic spherical liquid crystal state having a sufficient particle size can be obtained. As such a method, the above-mentioned amphiphilic substance and / or polycondensation polymer having a hydroxyl group is added to a dispersion medium (that is, water) and stirred for a long time. After the particles are dissolved in a good solvent, the solution is mixed with water (for example, see JP-A-2006-241424). Thereby, the above-mentioned moisture evaporation suppression effect improves more. Specifically, the above step is preferably performed until the particles of the closed vesicles or the polycondensation polymer in the emulsifier dispersion exhibit an average particle diameter of 8 nm or more and 800 nm or less.
重縮合ポリマーの単粒子化は、重縮合ポリマー粒子の結合体を含む顆粒を、水に分散して分散液を調製した後、顆粒を膨潤し、更に顆粒に由来する水素結合を可逆的条件下で切断することで、結合体の高次構造が緩和された緩和物を生成し、時間を置いた後、結合体内の水素結合を切断し、重縮合ポリマー粒子を水中に分離することで行われることが好ましい。この過程を経ない場合、重縮合ポリマー粒子(単粒子〜数個の単粒子の集合)が十分には得られにくい。 Single particles of polycondensation polymer are prepared by dispersing granules containing a conjugate of polycondensation polymer particles in water, preparing a dispersion, then swelling the granules, and further reversing the hydrogen bonds derived from the granules under reversible conditions. The product is relaxed by generating a relaxed product in which the higher order structure of the conjugate is relaxed, and after a while, hydrogen bonds in the conjugate are broken and the polycondensation polymer particles are separated into water. It is preferable. If this process is not performed, it is difficult to sufficiently obtain polycondensation polymer particles (single particles to several single particles).
O/Wエマルションを形成する工程において、抱水性油剤相に含まれる液状油成分の配合量は、O/Wエマルションに対して10質量%未満であることが好ましい。これにより、液状油成分によるリオトロピック球状液晶化の阻害が抑制される。液状油成分が多量に必要である場合には、液状油成分の乳化物を別途調製し、本発明の乳化物と混合することが好ましい。 In the step of forming the O / W emulsion, the blending amount of the liquid oil component contained in the hydrated oil phase is preferably less than 10% by mass with respect to the O / W emulsion. Thereby, inhibition of lyotropic spherical liquid crystal formation by a liquid oil component is suppressed. When a large amount of the liquid oil component is required, it is preferable to separately prepare an emulsion of the liquid oil component and mix it with the emulsion of the present invention.
O/Wエマルションを形成する工程において、抱水性油剤の配合量が、O/Wエマルションに対して1質量%超であることが好ましい。これにより、リオトロピック球状液晶物の高い水分蒸散抑制効果をより向上することができる。 In the step of forming the O / W emulsion, it is preferable that the amount of the water-containing oil agent is more than 1% by mass with respect to the O / W emulsion. Thereby, the high moisture evaporation suppression effect of a lyotropic spherical liquid crystal substance can be improved more.
また、O/Wエマルションを形成した後は、内相(抱水性油剤を含む油相)の液晶形成を阻害しないよう、エマルションを徐々に冷却することが好ましい。特に限定されないが、1時間あたり30〜120℃程度の速度で冷却すればよい。 Moreover, after forming the O / W emulsion, it is preferable to gradually cool the emulsion so as not to inhibit the liquid crystal formation of the internal phase (an oil phase containing a water-containing oil agent). Although it does not specifically limit, What is necessary is just to cool at the speed | rate about 30-120 degreeC per hour.
本発明の外用剤は、皮膚又は毛髪に適用されるものであるが、例えば、皮膚又は毛髪に適用される化粧料として使用することができる。本発明における化粧料とは、いわゆる化粧料に加えて医薬部外品(薬用化粧料)までを包含する概念を意味する。化粧料の具体的な形態は、特に限定されないが、クリーム、オイル美容液、洗顔料、クレンジング、リップ製剤(口紅、口紅の下地)等の皮膚用化粧料、ヘアトリートメント、スタイリング剤、パーマ・カラーの前後処理剤等の髪用化粧料、化粧品と類似した剤型で薬事法の対象外の製品(いわゆる、雑品)であってよい。これらのうち、本発明の外用剤は、密着性、付着性、べたつきのなさ、しっとり感及びその持続効果、被膜感、ツヤ持続性、シワ改善効果、保湿効果に優れることから、リップ製剤として用いることが好ましい。また、本発明の外用剤は、保湿効果に優れることから、保湿性が求められる製剤(例えば、目元用製剤、爪用製剤)として用いられることが好ましい。本発明の外用剤は、使用される用途に応じて、適宜他の成分を含んでよい。 Although the external preparation of this invention is applied to skin or hair, it can be used as cosmetics applied to skin or hair, for example. The cosmetic in the present invention means a concept including quasi-drugs (medicinal cosmetics) in addition to so-called cosmetics. Specific forms of cosmetics are not particularly limited, but skin cosmetics such as creams, oil serums, facial cleansers, cleansings, lip preparations (lipsticks, lipstick bases), hair treatments, styling agents, permanent colors It may be a product (so-called miscellaneous goods) that is not subject to the Pharmaceutical Affairs Law and has a dosage form similar to that of hair cosmetics such as pre- and post-treatment agents and cosmetics. Among these, the external preparation of the present invention is used as a lip preparation because it is excellent in adhesion, adhesion, non-stickiness, moist feeling and its long-lasting effect, coating feeling, gloss persistence, wrinkle improving effect, and moisturizing effect. It is preferable. Moreover, since the external preparation of this invention is excellent in a moisturizing effect, it is preferable to be used as a formulation (for example, eye preparation, nail preparation) that requires moisturizing properties. The external preparation of the present invention may appropriately contain other components depending on the intended use.
<リオトロピック球状液晶の安定性の確認>
(参考例1)
スルホン化セルロース誘導体粒子の分散液を調製した。1,2−ペンダンジオール、1,3−ブチレングリコールを加え、この分散液を80℃に加熱し、温水を加え、更に80℃の水添ナタネ油アルコールを加え、ホモミキサーにより6000rpm、80℃、10分間に亘って撹拌し、乳化を行った。その後、15分間かけて放冷し、更に35℃まで水冷することで、リオトロピック球状液晶を有する乳化物を調製した。なお、各成分の配合割合は、表1に示すとおりである。
<Confirmation of stability of lyotropic spherical liquid crystal>
(Reference Example 1)
A dispersion of sulfonated cellulose derivative particles was prepared. 1,2-Pendanediol and 1,3-butylene glycol were added, the dispersion was heated to 80 ° C., warm water was added, hydrogenated rapeseed oil alcohol at 80 ° C. was added, and 6000 rpm, 80 ° C., The mixture was stirred for 10 minutes for emulsification. Thereafter, the mixture was allowed to cool for 15 minutes and further cooled to 35 ° C. to prepare an emulsion having lyotropic spherical liquid crystals. In addition, the compounding ratio of each component is as shown in Table 1.
(安定性確認)
参考例1の乳化物をガラスプレートに球状ラメラ製剤を1滴垂らし、40℃の恒温槽へ保管した。保管前と、保管から7日経過後のリオトロピック球状液晶を顕微鏡により確認した。その結果を図1に示す。図1に示すように、40℃で7日経過しても、リオトロピック球状液晶は安定に維持されていたことがわかった。
(Stability confirmation)
One drop of the spherical lamella preparation was dropped on the glass plate of Reference Example 1 and stored in a constant temperature bath at 40 ° C. The lyotropic spherical liquid crystal was confirmed with a microscope before storage and after 7 days from storage. The result is shown in FIG. As shown in FIG. 1, it was found that the lyotropic spherical liquid crystal was stably maintained even after 7 days at 40 ° C.
<実施例1〜6、比較例1>
実施例1〜6、比較例1の外用剤を、以下の表2の配合で調製した。具体的には、まず、スルホン化セルロース誘導体粒子の分散液を調製した。1,2−ペンダンジオール、1,3−ブチレングリコールを加え、この分散液を80℃に加熱し、温水を加え、更に80℃の水添ナタネ油アルコールを加え、ホモミキサーにより6000rpm、80℃、10分間に亘って撹拌し、乳化を行った。その後、15分間かけて放冷し、更に35℃まで水冷することで、リオトロピック球状液晶を有する乳化物を調製した。他方、パルミチン酸デキストリンをミネラルオイルに添加し、100℃以上に加温してパルミチン酸デキストリンの溶解を確認後、放冷することでオイルゲルを調製した後、乳化物とオイルゲルとを混合し、実施例1〜6、比較例1の外用剤を調製した。
<Examples 1 to 6, Comparative Example 1>
The external preparations of Examples 1 to 6 and Comparative Example 1 were prepared with the formulations shown in Table 2 below. Specifically, first, a dispersion of sulfonated cellulose derivative particles was prepared. 1,2-Pendanediol and 1,3-butylene glycol were added, the dispersion was heated to 80 ° C., warm water was added, hydrogenated rapeseed oil alcohol at 80 ° C. was added, and 6000 rpm, 80 ° C., The mixture was stirred for 10 minutes for emulsification. Thereafter, the mixture was allowed to cool for 15 minutes and further cooled to 35 ° C. to prepare an emulsion having lyotropic spherical liquid crystals. On the other hand, dextrin palmitate is added to mineral oil, heated to 100 ° C or higher to confirm dissolution of dextrin palmitate, and then allowed to cool to prepare an oil gel, followed by mixing the emulsion and oil gel External preparations of Examples 1 to 6 and Comparative Example 1 were prepared.
<比較例2>
比較例2の外用剤を、以下の表2の配合で調製した。具体的には、パルミチン酸デキストリンをミネラルオイルに添加し、100℃以上に加温してパルミチン酸デキストリンの溶解を確認後、放冷することでオイルゲルを調製した後、1,2−ペンダンジオール、1,3−ブチレングリコールとオイルゲル中とを混合し、比較例2の外用剤を調製した。
<Comparative example 2>
The external preparation of Comparative Example 2 was prepared with the formulation shown in Table 2 below. Specifically, dextrin palmitate is added to mineral oil, heated to 100 ° C. or higher to confirm dissolution of dextrin palmitate, and then allowed to cool to prepare an oil gel, 1,2-pendanediol, 1,3-butylene glycol and the oil gel were mixed to prepare an external preparation of Comparative Example 2.
<比較例3>
比較例3の外用剤を、以下の表2の配合で調製した。具体的には、パルミチン酸デキストリンをミネラルオイルに添加し、100℃以上に加温してパルミチン酸デキストリンの溶解を確認後、放冷することでオイルゲルを調製し、これを比較例3の外用剤とした。
<Comparative Example 3>
The external preparation of Comparative Example 3 was prepared with the formulation shown in Table 2 below. Specifically, dextrin palmitate is added to mineral oil, heated to 100 ° C. or higher to confirm dissolution of dextrin palmitate, and then allowed to cool to prepare an oil gel. It was.
<リオトロピック球状液晶の確認>
実施例1〜6の外用剤について、リオトロピック球状液晶が形成されているかを顕微鏡により観察した。その結果を図2に示す。図2中、(a)が実施例1、(b)が実施例2、(c)が実施例3、(d)が実施例4、(e)が実施例5、(f)が実施例6、(g)が比較例1のぞれぞれの画像を示す。図2に示すように、抱水性油剤の配合量が少ない比較例1ではリオトロピック球状液晶の形成されていなかったが、抱水性油剤の配合量が0.015質量%超である実施例1〜6の全ての外用剤において、リオトロピック球状液晶が形成されていることが確認できた。
<Confirmation of lyotropic spherical liquid crystal>
About the external preparation of Examples 1-6, it was observed with the microscope whether the lyotropic spherical liquid crystal was formed. The result is shown in FIG. 2, (a) is Example 1, (b) is Example 2, (c) is Example 3, (d) is Example 4, (e) is Example 5, and (f) is Example. 6 and (g) show images of Comparative Example 1, respectively. As shown in FIG. 2, although the lyotropic spherical liquid crystal was not formed in Comparative Example 1 with a small amount of the water-holding oil, Examples 1 to 6 in which the amount of the water-containing oil was more than 0.015% by mass. It was confirmed that lyotropic spherical liquid crystals were formed in all of the external preparations.
<テープストリッピング後のTEWL回復試験>
20代〜40代男性5名の被験者に、実施例2、比較例2の外用剤を用い、テープストリッピング後のTEWL回復試験を行った。具体的には、まず、被験者の左前腕内側をシャボン玉石けんで洗浄し、幅1.8cm、長さ3cmのセロハンテープで7回貼付→剥離を繰り返した。その後、剥離部位の塗布前に角層水分蒸散量(テヴァメーター)を測定した。その後、実施例2、比較例2の外用剤をそれぞれ米粒1粒程度塗布し、塗布15分後に角層水分蒸散量(テヴァメーター)を測定した。その結果を、図3に示す。
<TEWL recovery test after tape stripping>
A TEWL recovery test after tape stripping was performed on five subjects in their 20s to 40s using the external preparations of Example 2 and Comparative Example 2. Specifically, first, the inside of the subject's left forearm was washed with soap bubble soap, and was applied 7 times with a cellophane tape having a width of 1.8 cm and a length of 3 cm. Thereafter, the stratum corneum moisture transpiration (tevameter) was measured before application of the peeled portion. Thereafter, about 1 rice grain was applied to each of the external preparations of Example 2 and Comparative Example 2, and the stratum corneum moisture transpiration (tevameter) was measured 15 minutes after the application. The result is shown in FIG.
図3に示すように、使用前のTEWL平均値を1としたとき、実施例2の外用剤の方がリオトロピック球状液晶を有さない比較例2の外用剤より、TEWL値の低下がみられ、変化率が大きかったことから、実施例2のTEWLの改善効果が大きいことがわかった。 As shown in FIG. 3, when the TEWL average value before use is 1, the external preparation of Example 2 has a lower TEWL value than the external preparation of Comparative Example 2 that does not have lyotropic spherical liquid crystals. From the fact that the rate of change was large, it was found that the improvement effect of TEWL of Example 2 was large.
<カップ法による水分蒸散抑制試験1>
実施例1〜6、比較例2、3の外用剤を用いて、カップ法による水分蒸散抑制試験を行った。まず、ガラス瓶に50gの水を入れ、その上に不織布を置き、不織布の上に各外用剤を0.5g塗布した。60℃で96時間インキュベートした後、サンプル(ガラス瓶中に残る水)の重さを測定し、インキュベート前のサンプル重量を100%としたときの水分残存率を評価した(n=3)。また、コントロールとして何も塗布していない不織布を準備し、これの水分残存率も評価した(対照例1)。その結果を図4に示す。なお、水分残存率が高いほど、ガラス瓶内の水分の蒸散が抑制されたことを意味する。
<Moisture transpiration suppression test 1 by cup method>
Using the external preparations of Examples 1 to 6 and Comparative Examples 2 and 3, a moisture transpiration suppression test by the cup method was performed. First, 50 g of water was put in a glass bottle, a nonwoven fabric was placed thereon, and 0.5 g of each external preparation was applied on the nonwoven fabric. After incubating at 60 ° C. for 96 hours, the weight of the sample (water remaining in the glass bottle) was measured, and the water residual rate was evaluated when the sample weight before incubation was taken as 100% (n = 3). Moreover, the nonwoven fabric which has not apply | coated nothing was prepared as control, and the moisture residual rate of this was also evaluated (control example 1). The result is shown in FIG. In addition, it means that the transpiration of the water | moisture content in a glass bottle was suppressed, so that a moisture residual rate is high.
図4に示すように、リオトロピック球状液晶を有する実施例1〜6の外用剤は、全て、リオトロピック球状液晶を有さない比較例2、3の外用剤より水分残存率が高いこと、すなわち、水分の蒸散が抑制されることがわかった。 As shown in FIG. 4, all of the external preparations of Examples 1 to 6 having lyotropic spherical liquid crystals have a higher water residual ratio than the external preparations of Comparative Examples 2 and 3 having no lyotropic spherical liquid crystals, that is, moisture. It was found that transpiration was suppressed.
<比較例4>
比較例4の外用剤を、以下の表3の配合で調製した。具体的には、まず、スルホン化セルロース誘導体粒子の分散液を調製した。この分散液に、ミリスチン酸オクチルドデシル、1,2−ペンダンジオール、1,3ブチレングリコールを加え、ホモミキサーにより6000rpm、80℃、10分間に亘って撹拌し、三相乳化法によりリオトロピック球状液晶を有さない乳化物を調製した。他方、パルミチン酸デキストリンをミネラルオイルに添加し、100℃以上に加温してパルミチン酸デキストリンの溶解を確認後、放冷することでオイルゲルを調製し、乳化物とオイルゲルとを混合し、比較例4の外用剤を調製した。
<Comparative example 4>
The external preparation of Comparative Example 4 was prepared with the formulation shown in Table 3 below. Specifically, first, a dispersion of sulfonated cellulose derivative particles was prepared. To this dispersion, octyldodecyl myristate, 1,2-pentanediol, and 1,3-butylene glycol were added, and the mixture was stirred with a homomixer at 6000 rpm, 80 ° C. for 10 minutes. An emulsion without was prepared. On the other hand, dextrin palmitate is added to mineral oil, heated to 100 ° C or higher to confirm dissolution of dextrin palmitate, and then allowed to cool to prepare an oil gel, and the emulsion and the oil gel are mixed. Four external preparations were prepared.
<実施例7>
実施例7の外用剤を、以下の表3の配合で調製した。具体的には、水添ナタネ油アルコールをステアリルアルコールに変更し、各成分の配合割合を変更した点以外は、実施例1と同様の方法により、実施例7の外用剤を調製した。実施例7の各成分の配合割合は、表3に示すとおりである。
<Example 7>
The external preparation of Example 7 was prepared with the formulation shown in Table 3 below. Specifically, the external preparation of Example 7 was prepared by the same method as Example 1 except that the hydrogenated rapeseed oil alcohol was changed to stearyl alcohol and the blending ratio of each component was changed. The blending ratio of each component of Example 7 is as shown in Table 3.
<実施例8>
実施例8の外用剤を、以下の表3の配合で調製した。具体的には、1,2−ペンダンジオール、1,3ブチレングリコールを加えず、各成分の配合割合を変更した点以外は、実施例1と同様の方法により、実施例8の外用剤を調製した。
<Example 8>
The external preparation of Example 8 was prepared with the formulation shown in Table 3 below. Specifically, the external preparation of Example 8 was prepared in the same manner as in Example 1 except that 1,2-pentanediol and 1,3 butylene glycol were not added and the blending ratio of each component was changed. did.
<実施例9>
実施例9の外用剤を、以下の表3の配合で調製した。具体的には、マイクロクリスタリンワックスを加え、各成分の配合割合を変更した点以外は、実施例1と同様の方法により、実施例9の外用剤を調製した。
<Example 9>
The external preparation of Example 9 was prepared with the formulation shown in Table 3 below. Specifically, the external preparation of Example 9 was prepared in the same manner as in Example 1 except that microcrystalline wax was added and the blending ratio of each component was changed.
<実施例10、11>
実施例10、11の外用剤を、以下の表3の配合で調製した。具体的には、各成分の配合割合を変更した点以外は、実施例1と同様の方法により、実施例10、11の外用剤を調製した。
<Examples 10 and 11>
External preparations of Examples 10 and 11 were prepared with the formulations shown in Table 3 below. Specifically, external preparations of Examples 10 and 11 were prepared by the same method as Example 1 except that the blending ratio of each component was changed.
<実施例12>
実施例12の外用剤を、以下の表3の配合で調製した。具体的には、各成分の配合割合を変更した点以外は、実施例7と同様の方法により、実施例12の外用剤を調製した。なお、実施例12の外用剤は、後述の目元用製剤における試験において使用されるものである。
<Example 12>
The external preparation of Example 12 was prepared with the formulation shown in Table 3 below. Specifically, the external preparation of Example 12 was prepared in the same manner as in Example 7 except that the blending ratio of each component was changed. In addition, the external preparation of Example 12 is used in the test in the below-mentioned eye preparation.
<比較例5>
比較例5の外用剤を、以下の表3の配合で調製した。具体的には、マイクロクリスタリンワックスを加え、各成分の配合割合を変更した点以外は、比較例3と同様の方法により、比較例5の外用剤を調製した。
<Comparative Example 5>
The external preparation of Comparative Example 5 was prepared with the formulation shown in Table 3 below. Specifically, the external preparation of Comparative Example 5 was prepared by the same method as Comparative Example 3 except that microcrystalline wax was added and the blending ratio of each component was changed.
<参考例2>
参考例2のヒアルロン酸水溶液を、以下の表3の配合で調製した。具体的には、水とミネラルオイルとパルミチン酸デキストリンとヒアルロン酸とを表3の割合になるように配合し、参考例2のヒアルロン酸水溶液を調製した。
<Reference Example 2>
The hyaluronic acid aqueous solution of Reference Example 2 was prepared with the formulation shown in Table 3 below. Specifically, water, mineral oil, dextrin palmitate and hyaluronic acid were blended in the proportions shown in Table 3 to prepare the hyaluronic acid aqueous solution of Reference Example 2.
<カップ法による水分蒸散抑制試験2>
実施例2、比較例2、4の外用剤を用いて、カップ法による水分蒸散抑制試験を行った。まず、ガラス瓶に150gの水を入れ、その上に不織布を置き、不織布の上に各外用剤を1g塗布した。60℃で96時間インキュベートした後、サンプル(ガラス瓶中に残る水)の重さを測定し、水分残存率を評価した。その結果を図5に示す。図5に示すように、三相乳化物であってもリオトロピック球状液晶を有さない比較例4より、実施例2の方が水分蒸散抑制効果が認められたことから、リオトロピック球状液晶が水分蒸散抑制に寄与していることが示唆された。
<Moisture transpiration suppression test 2 by cup method>
Using the external preparations of Example 2 and Comparative Examples 2 and 4, a moisture transpiration suppression test by the cup method was performed. First, 150 g of water was put in a glass bottle, a nonwoven fabric was placed thereon, and 1 g of each external preparation was applied on the nonwoven fabric. After incubating at 60 ° C. for 96 hours, the weight of the sample (water remaining in the glass bottle) was measured to evaluate the moisture remaining rate. The result is shown in FIG. As shown in FIG. 5, since the water transpiration suppression effect was recognized in Example 2 as compared with Comparative Example 4 having no lyotropic spherical liquid crystal even in the case of a three-phase emulsion, the lyotropic spherical liquid crystal was water transpiration. It was suggested that it contributed to suppression.
<カップ法による水分蒸散抑制試験3>
実施例6〜8、比較例3の外用剤を用いて、カップ法による水分蒸散抑制試験を行った。まず、ガラス瓶に50gの水を入れ、その上に不織布を置き、不織布の上に各外用剤を0.5g塗布した。60℃で96時間インキュベートした後、サンプル(ガラス瓶中に残る水)の重さを測定し、水分残存率を評価した。その結果を図6、図7に示す。
<Moisture transpiration suppression test 3 by cup method>
Using the external preparations of Examples 6 to 8 and Comparative Example 3, a moisture transpiration suppression test by the cup method was performed. First, 50 g of water was put in a glass bottle, a nonwoven fabric was placed thereon, and 0.5 g of each external preparation was applied on the nonwoven fabric. After incubating at 60 ° C. for 96 hours, the weight of the sample (water remaining in the glass bottle) was measured to evaluate the moisture remaining rate. The results are shown in FIGS.
図6に示すように、リオトロピック球状液晶において水添ナタネ油アルコールとは炭素数が異なる長鎖アルコール(高級アルコール)であるステアリルアルコールを用いた実施例7においても、水分蒸散抑制効果がみられた。このことから、炭素数が一定以上のリオトロピック液晶を形成する抱水性油剤であればよく、リオトロピック球状液晶であることが重要であることがわかった。 As shown in FIG. 6, in Example 7 using stearyl alcohol, which is a long-chain alcohol (higher alcohol) having a carbon number different from that of hydrogenated rapeseed oil alcohol in the lyotropic spherical liquid crystal, an effect of suppressing moisture transpiration was observed. . From this, it has been found that any hydrated oil agent that forms a lyotropic liquid crystal having a certain number of carbon atoms or more, and it is important to be a lyotropic spherical liquid crystal.
図7に示すように、1,2−ペンダンジオール、1,3−ブチレングリコールを含まない実施例8においても、水分蒸散抑制効果がみられた。このことから、1,2−ペンダンジオール、1,3−ブチレングリコールがなくても、リオトロピック球状液晶を含むことで水分蒸散抑制効果を得られることが確認された。 As shown in FIG. 7, the moisture transpiration suppression effect was also observed in Example 8 which does not contain 1,2-pentanediol and 1,3-butylene glycol. From this, it was confirmed that even if there is no 1,2-pentanediol or 1,3-butylene glycol, the moisture evaporation suppression effect can be obtained by including the lyotropic spherical liquid crystal.
<カップ法による水分蒸散抑制試験4>
実施例2、9〜11、比較例3、5の外用剤を用いて、カップ法による水分蒸散抑制試験を行った。まず、ガラス瓶に50gの水を入れ、その上に不織布を置き、不織布の上に各外用剤を0.5g塗布した。60℃で96時間インキュベートした後、サンプル(ガラス瓶中に残る水)の重さを測定し、水分残存率を評価した。その結果を図8、図9に示す。
<Water transpiration suppression test 4 by cup method>
Using the external preparations of Examples 2 and 9 to 11 and Comparative Examples 3 and 5, a moisture transpiration suppression test by the cup method was performed. First, 50 g of water was put in a glass bottle, a nonwoven fabric was placed thereon, and 0.5 g of each external preparation was applied on the nonwoven fabric. After incubating at 60 ° C. for 96 hours, the weight of the sample (water remaining in the glass bottle) was measured to evaluate the moisture remaining rate. The results are shown in FIGS.
図8に示すように、外相にマイクロクリスタリンワックスを用い、硬いバーム状の実施例9においても、水分蒸散抑制効果がみられた。このことから、外相のオイルゲルがバーム状であっても、リオトロピック球状液晶を含むことで水分蒸散抑制効果を得られることがわかった。 As shown in FIG. 8, the moisture evaporation suppression effect was also observed in the hard balm-like Example 9 using microcrystalline wax for the outer phase. From this, it was found that even when the oil gel of the outer phase is balm, the effect of suppressing moisture transpiration can be obtained by including the lyotropic spherical liquid crystal.
図9に示すように、実施例10、11のいずれにおいても、水分蒸散抑制効果がみられた。このことから、1,2−ペンタンジオールや1,3−ブチレングリコール等の量に依存せずに、リオトロピック球状液晶を含むことで水分蒸散抑制効果を得られることがわかった。 As shown in FIG. 9, in any of Examples 10 and 11, a moisture transpiration suppressing effect was observed. From this, it was found that moisture transpiration suppression effect can be obtained by including lyotropic spherical liquid crystal without depending on the amount of 1,2-pentanediol, 1,3-butylene glycol and the like.
<カップ法による水分蒸散抑制試験5>
実施例2の外用剤、参考例2のヒアルロン酸水溶液、比較例2の外用剤を用いて、カップ法による水分蒸散抑制試験を行った。まず、ガラス瓶に150gの水を入れ、その上に不織布を置き、不織布の上に各外用剤を1g塗布した。60℃で96時間インキュベートした後、サンプル(ガラス瓶中に残る水)の重さを測定し、水分残存率を評価した。その結果を図10に示す。図10に示すように、三相乳化物によるリオトロピック球状液晶は、ヒアルロン酸と同程度の水分蒸散抑制効果を有することがわかった。
<Moisture transpiration suppression test 5 by cup method>
Using the external preparation of Example 2, the aqueous hyaluronic acid solution of Reference Example 2, and the external preparation of Comparative Example 2, a moisture transpiration suppression test by the cup method was performed. First, 150 g of water was put in a glass bottle, a nonwoven fabric was placed thereon, and 1 g of each external preparation was applied on the nonwoven fabric. After incubating at 60 ° C. for 96 hours, the weight of the sample (water remaining in the glass bottle) was measured to evaluate the moisture remaining rate. The result is shown in FIG. As shown in FIG. 10, it was found that the lyotropic spherical liquid crystal by the three-phase emulsion has the same moisture transpiration inhibiting effect as that of hyaluronic acid.
<リップ製剤としての官能評価1>
実施例2、比較例2の外用剤のリップ製剤としての官能評価を行った。具体的には、まず、それぞれの外用剤を唇に塗布し、表4中の(1)〜(10)の項目を評価した。評価は、1〜7点で評価し、点数が高いほど評価が高いものとした。評価は、20〜30代女性3名により行った。その平均点を以下の表4に示す。
<Sensory evaluation 1 as a lip preparation>
The sensory evaluation as a lip formulation of the external preparation of Example 2 and Comparative Example 2 was performed. Specifically, first, each external preparation was applied to the lips, and the items (1) to (10) in Table 4 were evaluated. Evaluation was evaluated with 1 to 7 points, and the higher the score, the higher the evaluation. Evaluation was performed by three women in their 20s to 30s. The average points are shown in Table 4 below.
表4に示すとおり、「べたつきのなさ」「直後のしっとり感」や「しっとり感の持続性」、「口紅との相性」等、全体的な評価において、リオトロピック球状液晶を有する実施例2の方が比較例2より評価が優れていた。 As shown in Table 4, in the overall evaluation, such as “no stickiness”, “moist feeling immediately after”, “persistence of moist feeling”, “compatibility with lipstick”, etc., Example 2 having lyotropic spherical liquid crystal However, the evaluation was superior to that of Comparative Example 2.
<目元用製剤としての官能評価>
実施例12の外用剤の目元用製剤としての官能評価を行った。具体的には、まず、外用剤を目元に塗布し、表5中の各項目を評価した。評価は、1〜5点で評価し、点数が高いほど評価が高いものとした。評価は、20〜30代女性3名により行った。その平均点を以下の表5に示す。
<Sensory evaluation as a preparation for the eye area>
Sensory evaluation as a preparation for the eye of the external preparation of Example 12 was performed. Specifically, first, an external preparation was applied to the eyes, and each item in Table 5 was evaluated. Evaluation was evaluated with 1 to 5 points, and the higher the score, the higher the evaluation. Evaluation was performed by three women in their 20s to 30s. The average score is shown in Table 5 below.
表5に示すように、全体的に評価が高く、高い保湿性を有することがわかった。このことから、目元、爪等の保湿製剤としての利用に適していることがわかった。 As shown in Table 5, the overall evaluation was high, and it was found to have high moisture retention. From this, it was found that it is suitable for use as a moisturizing preparation such as eyes and nails.
<口紅の下地としての評価>
実施例2、比較例2の外用剤の口紅の下地としての官能評価を行った。また、これらのほかに、ミネラルオイル94.55%、マイクロクリスタリンワックス0.15%、パルミチン酸デキストリン5%の割合で調製した外相に固形油を有する外用剤(比較例6)を準備し、これについても口紅の下地としての官能評価を行った。
<Evaluation as a base for lipstick>
The sensory evaluation as a base of the lipstick of the external preparation of Example 2 and Comparative Example 2 was performed. In addition to these, an external preparation (Comparative Example 6) having solid oil in the outer phase prepared in a ratio of 94.55% mineral oil, 0.15% microcrystalline wax and 5% dextrin palmitate was prepared. As for the lipstick, a sensory evaluation was performed as a foundation for lipstick.
具体的な評価の方法としては、まず、上腕内側にそれぞれ製剤を塗布し、5分置いた。その後スティック口紅を塗布し、観察外用剤を目元に塗布し、観察して肌との均一密着性を評価した。評価は、1〜5点で評価し、点数が高いほど評価が高いものとした。その評価結果を表6に示す。 As a specific evaluation method, first, each preparation was applied to the inner side of the upper arm and left for 5 minutes. Thereafter, a stick lipstick was applied, and an external preparation for observation was applied to the eyes and observed to evaluate uniform adhesion to the skin. Evaluation was evaluated with 1 to 5 points, and the higher the score, the higher the evaluation. The evaluation results are shown in Table 6.
表6に示すように、リオトロピック球状液晶を有する実施例2が、最も均一密着性が高かったことから、口紅の下地に適していることがわかった。 As shown in Table 6, Example 2 having a lyotropic spherical liquid crystal had the highest uniform adhesion, indicating that it was suitable for a lipstick substrate.
<実施例12>
スルホン化セルロース誘導体粒子をレシチンに置き換えた点以外は、実施例1と同様の手順で、下記表7に示すとおりの配合で、実施例12の外用剤を調製した。なお、下記表7には、上述の比較例2の配合も併記している。
<Example 12>
Except that the sulfonated cellulose derivative particles were replaced with lecithin, an external preparation of Example 12 was prepared in the same procedure as in Example 1 with the formulation shown in Table 7 below. In Table 7 below, the composition of Comparative Example 2 described above is also shown.
<カップ法による水分蒸散抑制試験6>
実施例12の外用剤、比較例2の外用剤を用いて、カップ法による水分蒸散抑制試験を行った。まず、ガラス瓶に50gの水を入れ、その上に不織布を置き、不織布の上に各外用剤を0.5g塗布した。60℃で96時間インキュベートした後、サンプル(ガラス瓶中に残る水)の重さを測定し、水分残存率を評価した。その結果、リオトロピック球状液晶を有する実施例12の水分残存率は89.39%であったのに対し、比較例2の水分残存率は85.97%であった。このようにレシチンを閉鎖小胞体として用いた場合も、同様に水分蒸散を抑制できることがわかった。
<Moisture transpiration suppression test 6 by cup method>
Using the external preparation of Example 12 and the external preparation of Comparative Example 2, a moisture transpiration suppression test by the cup method was performed. First, 50 g of water was put in a glass bottle, a nonwoven fabric was placed thereon, and 0.5 g of each external preparation was applied on the nonwoven fabric. After incubating at 60 ° C. for 96 hours, the weight of the sample (water remaining in the glass bottle) was measured to evaluate the moisture remaining rate. As a result, the residual moisture rate of Example 12 having lyotropic spherical liquid crystals was 89.39%, while the residual moisture rate of Comparative Example 2 was 85.97%. Thus, it was found that when lecithin is used as a closed endoplasmic reticulum, water transpiration can be similarly suppressed.
<リップ製剤としての官能評価1>
実施例12、比較例2の外用剤のリップ製剤としての官能評価を行った。具体的には、まず、それぞれの外用剤を唇に塗布し、表8中の各項目を評価した。評価は、1〜7点で評価し、点数が高いほど評価が高いものとした。評価は、20〜30代女性3名により行った。その平均点を以下の表8に示す。
<Sensory evaluation 1 as a lip preparation>
The sensory evaluation as a lip preparation of the external preparation of Example 12 and Comparative Example 2 was performed. Specifically, each external preparation was first applied to the lips, and each item in Table 8 was evaluated. Evaluation was evaluated with 1 to 7 points, and the higher the score, the higher the evaluation. Evaluation was performed by three women in their 20s to 30s. The average points are shown in Table 8 below.
表8に示すとおり、全体的な評価において、リオトロピック球状液晶を有する実施例12の方が比較例2より評価が優れていた。このようにレシチンを閉鎖小胞体として用いた場合も、同様にリップ製剤に適してることがわかった。 As shown in Table 8, in the overall evaluation, Example 12 having lyotropic spherical liquid crystals was superior to Comparative Example 2 in evaluation. Thus, when lecithin was used as a closed endoplasmic reticulum, it turned out that it is suitable for a lip formulation similarly.
Claims (2)
前記抱水性油剤濃度が0.015質量%超であって少なくとも一部がリオトロピック球状液晶状態で連続相としてのオイルゲル中に分散していることを特徴とする外用剤。 Comprising polycondensation polymer particles having closed vesicles or hydroxyl groups formed by a water-holding oil, water, and an amphiphile;
An external preparation characterized in that the concentration of the hydrated oil is greater than 0.015% by mass and at least a part of the hydrated oil is dispersed in an oil gel as a continuous phase in a lyotropic spherical liquid crystal state.
両親媒性物質が水相で形成する閉鎖小胞体、又は水酸基を有する重縮合ポリマー粒子、で構成された乳化剤によって抱水性油剤を水相に乳化分散したO/W型乳化液を、連続相としてのオイルゲル中に分散する工程を含み、
前記抱水性油剤の少なくとも一部がリオトロピック球状液晶を形成し、
前記抱水性油剤の配合量は、前記外用剤に対し0.015質量%以上である方法。
A method for producing an external preparation,
An O / W emulsion obtained by emulsifying and dispersing a water-containing oil in an aqueous phase with an emulsifier composed of closed endoplasmic reticulum formed by an amphiphilic substance in an aqueous phase or polycondensation polymer particles having a hydroxyl group, as a continuous phase A step of dispersing in an oil gel of
At least a portion of the hydrated oil forms a lyotropic spherical liquid crystal;
The amount of the hydrated oil is 0.015% by mass or more based on the external preparation.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2016250048A JP6869500B2 (en) | 2016-12-22 | 2016-12-22 | External preparations and methods for manufacturing external preparations |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2016250048A JP6869500B2 (en) | 2016-12-22 | 2016-12-22 | External preparations and methods for manufacturing external preparations |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2018104305A true JP2018104305A (en) | 2018-07-05 |
JP6869500B2 JP6869500B2 (en) | 2021-05-12 |
Family
ID=62786664
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2016250048A Active JP6869500B2 (en) | 2016-12-22 | 2016-12-22 | External preparations and methods for manufacturing external preparations |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6869500B2 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2020006326A (en) * | 2018-07-09 | 2020-01-16 | 学校法人神奈川大学 | Composition, manufacturing method thereof, emulsion and cosmetic |
JP2021059514A (en) * | 2019-10-08 | 2021-04-15 | 横浜油脂工業株式会社 | Oil-based cosmetics composed of hyaluronic acid oil and method for producing the same |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2014101294A (en) * | 2012-11-19 | 2014-06-05 | Pola Chem Ind Inc | O/w/o emulsifier-type skin external preparation |
-
2016
- 2016-12-22 JP JP2016250048A patent/JP6869500B2/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2014101294A (en) * | 2012-11-19 | 2014-06-05 | Pola Chem Ind Inc | O/w/o emulsifier-type skin external preparation |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2020006326A (en) * | 2018-07-09 | 2020-01-16 | 学校法人神奈川大学 | Composition, manufacturing method thereof, emulsion and cosmetic |
JP7107500B2 (en) | 2018-07-09 | 2022-07-27 | 学校法人神奈川大学 | COMPOSITION AND MANUFACTURING METHOD THEREOF, EMULSION, AND COSMETIC |
JP2021059514A (en) * | 2019-10-08 | 2021-04-15 | 横浜油脂工業株式会社 | Oil-based cosmetics composed of hyaluronic acid oil and method for producing the same |
Also Published As
Publication number | Publication date |
---|---|
JP6869500B2 (en) | 2021-05-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6707727B2 (en) | Emulsion and method for producing emulsion | |
JP4237446B2 (en) | Method for stabilizing nano-emulsified particles using tocopherol derivative and skin external preparation composition containing nano-emulsified particles | |
KR101515646B1 (en) | Skin external preparation in the form of water-in-oil emulsion comprising ceramide | |
TWI508750B (en) | Cosmetic base comprising collagen-modified liposome and skin cosmetic containing the same | |
TW200413020A (en) | Vesicle dispersion and cosmetic containing the same | |
JP7268132B2 (en) | topical composition | |
CN101543465A (en) | Cosmetic composition comprising imidopercarboxylic acid derivative and n-acylated amino acid ester | |
JP2008115162A (en) | Emulsifier for liquid crystal formation, liquid crystal forming emulsion composition containing the same and cosmetic containing liquid crystal forming emulsion composition | |
JP6959596B2 (en) | Topical skin agents and skin barrier function improvers | |
JP2018104305A (en) | External preparation and method for producing external preparation | |
JP7211818B2 (en) | Skin topical agent | |
JP6820463B2 (en) | Topical skin and anti-wrinkle agents | |
TWI841534B (en) | Skin external preparation and its manufacturing method | |
WO2005044217A1 (en) | Method for preparing phytosphingosine liposome composition | |
TWI833884B (en) | External preparations for skin or mucous membranes, methods of manufacturing the same, and bases for external preparations for skin or mucous membranes | |
JPS61204109A (en) | Emulsion-type composition for external use | |
JP2014141479A (en) | Method for improving percutaneous absorption of active ingredient, and cosmetic | |
JPH0669532B2 (en) | Oil-in-water emulsion composition | |
JP6600907B2 (en) | Hair dye composition | |
JP5900906B2 (en) | Method for producing cosmetic base and skin cosmetic | |
JPH06271420A (en) | Water absorption improver for cosmetics and skin external drugs | |
KR100245390B1 (en) | Low irritating cosmetic compositions containing alphahydroxy acids | |
JPS58223436A (en) | Emulsion composition | |
JPH0570323A (en) | Emulsified cosmetic | |
JP2020138946A (en) | Cleanser of skin or hair and method for producing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20191210 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20200909 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20200929 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20201127 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20210316 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20210406 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6869500 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |